1. Ma, Xinyue, Wang, Qiuman, Sun, Chenggong, Zhang, Qing, Kong, Beihua. 2023. Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis. In Cell reports, 42, 112944. doi:10.1016/j.celrep.2023.112944. https://pubmed.ncbi.nlm.nih.gov/37566545/
2. Li, Shu-Yu, Zhang, Nan, Zhang, Hao, Huang, Chen-Shen, Li, Xing-Rui. 2024. Deciphering the TCF19/miR-199a-5p/SP1/LOXL2 pathway: Implications for breast cancer metastasis and epithelial-mesenchymal transition. In Cancer letters, 597, 216995. doi:10.1016/j.canlet.2024.216995. https://pubmed.ncbi.nlm.nih.gov/38851313/
3. Tian, Yahui, Xin, Shaowei, Wan, Zitong, Xiong, Yanlu, Han, Yong. 2024. TCF19 promotes cell proliferation and tumor formation in lung cancer by activating the Raf/MEK/ERK signaling pathway. In Translational oncology, 45, 101978. doi:10.1016/j.tranon.2024.101978. https://pubmed.ncbi.nlm.nih.gov/38701650/
4. Yang, Grace H, Fontaine, Danielle A, Lodh, Sukanya, Roopra, Avtar, Davis, Dawn Belt. 2021. TCF19 Impacts a Network of Inflammatory and DNA Damage Response Genes in the Pancreatic β-Cell. In Metabolites, 11, . doi:10.3390/metabo11080513. https://pubmed.ncbi.nlm.nih.gov/34436454/
5. Ling, Yick Hin, Chen, Yingying, Leung, Kwok Nam, Chan, King Ming, Liu, W K. 2023. Cell cycle regulation of the psoriasis associated gene CCHCR1 by transcription factor E2F1. In PloS one, 18, e0294661. doi:10.1371/journal.pone.0294661. https://pubmed.ncbi.nlm.nih.gov/38128007/
6. Mondal, Payel, Gadad, Shrikanth S, Adhikari, Swagata, Prasad, Parash, Das, Chandrima. . TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 35, e21814. doi:10.1096/fj.202002486RR. https://pubmed.ncbi.nlm.nih.gov/34369624/
智鼠故事 
